Director, HR Business Operations

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

ESSENTIAL JOB FUNCTIONS :

The Human Resource Operations Director will lead and manage the strategic and operational aspects of HR Operations, including compensation, benefits, HRIS oversight, compliance and reporting, and HR budgeting. This is a critical role in supporting Kura’s growth as we prepare for commercialization, taking our existing strong foundation to the next level. The director will focus on developing best-in-class practices, optimizing current processes, and ensuring scalability to meet the demands of a rapidly evolving organization. This role is integral to our commitment to building a best-in-class employee experience, aligning our HR operations with organizational goals, and ensuring compliance across all HR functions. This position reports to the VP of HR and will work closely with the entire HR team.

Compensation Management

• Optimize and oversee competitive compensation programs that attract and retain top talent.
• Conduct regular market analysis and benchmarking to ensure compensation programs are scalable for growth, equitable, competitive, and aligned with company goals.
• Manage salary reviews, incentive programs, and merit-based adjustments.
• Work closely with finance and legal to support equity compensation programs.

Benefits Administration

HRIS Oversight

Compliance, Auditing, and Reporting

HR Operations

HR Metrics, Dashboards, and Insights

HR Budget Management

JOB SPECIFICATIONS :

The base range for a Director is $194,063 - $215,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.

Kura’s Values that are used for candidate selection and performance assessments :

The Kura Package

Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company’s diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology’s approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.

Kura’s pipeline consists of three investigational drug candidates : ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R / R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R / R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R / R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1 / 2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.

Apply for this job

First Name

Last Name

Email

Phone

Resume / CV

Education

School

Degree

Start date year

End date month Select...

End date year

What is your preferred name?

Where did you hear about this job?

Are you open to considering relocation to Boston? Select...

Are you open to considering relocation to San Diego? Select...

Will you now or in the future require sponsorship for employment to work in the United States?

Why are you the best candidate for the job?

What are your salary expectations?

Why do you want to work for Kura Oncology?

Why are you looking for a new job?

Describe the work environment or culture and its management style in which you have experienced the most success.

If you were referred by a Kura employee, please share the name of who referred you.

J-18808-Ljbffr

Salary : $194,063 - $215,000